JD Health International Inc. (HKG:6618)
Hong Kong
· Delayed Price · Currency is HKD 60.20
+0.05 (0.08%)
At close: Dec 5, 2025
JD Health International Market Cap
JD Health International has a market cap or net worth of 192.73 billion as of December 5, 2025. Its market cap has increased by 127.95% in one year.
Market Cap
192.73B
Enterprise Value
139.18B
Revenue
71.34B
Ranking
n/a
PE Ratio
37.11
Stock Price
60.20
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 192.73B, a decrease of -43.97%. That is a compound annual growth rate of -10.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 192.73B | 114.43% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 277.93B |
| Hansoh Pharmaceutical Group Company | 253.90B |
| Innovent Biologics | 157.67B |
| WuXi Biologics | 134.32B |
| Sino Biopharmaceutical | 122.28B |
| Akeso | 114.31B |
| Sichuan Kelun-Biotech Biopharmaceutical | 107.27B |
| CSPC Pharmaceutical Group | 88.15B |